Advertisement

Topics

Six FDA updates in ophthalmology you might have missed this week

08:30 EST 6 Jan 2018 | Healio

The FDA granted clearances and made several other moves in the ophthalmology field this week.
Here are six FDA updates as reported on Healio.com/OSN:
 
Sight Sciences’ Omni Surgical System cleared by FDA
The Omni system is indicated for the delivery of controlled volumes of viscoelastic fluid in the anterior segment including Schlemm’s canal and the cutting of trabecular meshwork tissue. Read more.
 
Pixium Vision receives FDA approval to begin clinical study of Prima implant
Pixium Vision has received approval from the FDA to begin a clinical feasibility study for Prima, a

Original Article: Six FDA updates in ophthalmology you might have missed this week

NEXT ARTICLE

More From BioPortfolio on "Six FDA updates in ophthalmology you might have missed this week"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...